Form 483

Central Solutions, Inc. Form 483, 2019-11-21

FDA issued a Form 483 to Central Solutions, Inc. on 2019-11-21 with 18 public-safe observations.

483· Form 483 issuedHuman Drugs18 observations

Central Solutions, Inc. · Kansas City, United States · Issued November 21, 2019

Overview

  • 18 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

21 Nov 2019
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Rita K Kabaso

21 Nov 2019
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Rita K Kabaso

21 Nov 2019
21 CFR 211.160(a)

Deviations from laboratory control requirements

Cited by Rita K Kabaso

21 Nov 2019
21 CFR 211.160(a)

Deviations from laboratory control requirements

Cited by Rita K Kabaso

21 Nov 2019
21 CFR 211.166(a)

Written program not followed

Cited by Rita K Kabaso

Inspected site

CSCentral Solutions, Inc.Kansas City, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations4x
21 CFR 211.100(a)Cited across public-safe Form 483 observations2x
21 CFR 211.160(a)Cited across public-safe Form 483 observations2x
21 CFR 211.166(a)Cited across public-safe Form 483 observations2x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations2x
21 CFR 211.25(a)Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)(5)Cited across public-safe Form 483 observations2x
21 CFR 211.84(a)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 18 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere